BASF Sales, Earnings Miss Forecasts on Lower Margins, Write-Downs — Update
By Andrea Figueras
BASF said sales and earnings last year missed both the company's guidance and consensus expectations, dragged by write-downs and sales of lower-margin products.
Reporting preliminary figures, the German chemicals giant said Friday that it expects to book a 1.1 billion-euro ($1.20 billion) hit mainly related to noncash write-downs of its surface technologies, agricultural and materials segments.
Sales were EUR68.90 billion, according to the preliminary figures, down from EUR87.33 billion in 2022. The company had previously guided for sales of between EUR73 billion and EUR76 billion, while analysts had forecast EUR70.58 billion.
Earnings before interest and taxes before special items fell to EUR3.81 billion from EUR6.88 billion, the company said. This compared with its forecast range of EUR4.0 billion and EUR4.4 billion and analysts' consensus estimate of EUR3.93 billion.
BASF said it swung to a net profit of EUR225 million from a loss of EUR627 million a year earlier, when it was hit by impairments on Russia-related assets of its oil-and-gas business Wintershall Dea, but still missed analysts' expectations of EUR2.25 billion.
The company will publish its full 2023 report on Feb. 23.
Write to Andrea Figueras at andrea.figueras@wsj.com
(END) Dow Jones Newswires
January 19, 2024 02:17 ET (07:17 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What Does Nvidia’s Stock Split Mean for Investors?
-
5 Undervalued Stocks to Buy as Their Stories Play Out
-
Markets Brief: Return of the Meme Stocks
-
What’s Happening In the Markets This Week
-
It’s Been a Terrible Time for Bonds. Here’s Why You Should Own Them
-
Which AI Stocks Are Turning Hype Into Revenue?
-
Best- and Worst-Performing Stocks of May 2024
-
3 Stocks to Buy and 3 Stocks to Sell in June
-
The 10 Best Dividend Stocks
-
The Most Attractive Investment Opportunities in Oil & Gas
-
Apple: Generative AI Strategy Should Drive Sales and Upgrades
-
2 Undervalued Stocks That Just Raised Dividends
-
2 Popular Stocks That Top Managers Are Selling
-
The Best REITs to Buy
-
Nio Earnings: Revenue and Loss Largely In Line, but Vehicle Margin Missed Amid Price Competition
-
The Best Biotech Stocks to Buy